Diabetes Drugs Must Now Clear Cardiovascular Hurdle, Says FDA.

Test Your Knowledge Issue 448

Sherri Colberg Ph.D. has written a new book based on her experiences as an athlete and diabetes patient. The Diabetic Athlete's Handbook: Your guide to peak performance is reviewed this week by Shannon Hart, PharmD Candidate University of Florida...

In the largest study of its kind to date, researchers have shown that continually monitoring blood pressure (BP) — called ambulatory BP monitoring (ABPM) — is a predictor of future cardiovascular events in patients with resistant hypertension, but off...

Memory improved when carbs reintroduced to diet. Eliminating carbohydrates from your diet may help you lose weight, but it could leave you fuzzy headed and forgetful, a new study suggests.

A group of researchers conducted a study to investigate the role of blood glucose (BG) variability in glycemic control in patients with type 2 diabetes.

In people with type 2 diabetes, intensive drug therapy to significantly lower "bad" LDL cholesterol reduces the thickness of the carotid arteries, the major arteries in the neck that supply oxygen to the brain, research shows.

Adding to earlier research, a new study has identified a genetic variation that increases the risk of coronary artery disease (CAD) in type 2 diabetes patients with poor sugar glucose (glycemic) control.

The success of weight-loss in overweight and obese individuals with type 2 diabetes is not affected by a history of binge eating, according to a report in the Archives of General Psychiatry.

Phase 1 clinical trial of APD597, a novel first in class oral drug candidate that targets the glucose-dependent insulinotropic receptor (GDIR) for the treatment of type 2 diabetes will begin shortly. The GDIR has the potential to stimulate insulin...

Blood levels of two insulin-related proteins are able to predict which patients with colon cancer are most likely to die of their disease by 87%, new research suggests.

A once-daily, fixed-dose tablet combining atorvastatin and a novel micronized formulation of fenofibrate outperformed either drug alone in a phase II clinical trial in patients with mixed dyslipidemia.

Therapy with alogliptin alone is significantly reduced glycosylated hemoglobin A1c levels in patients with type 2 diabetes and inadequate glycemic control, according to a double-blind, placebo-controlled, multicenter trial reported this month.

Psoriasis and metabolic syndrome both are associated with high serum levels of leptin, according to a new report. "Body weight loss could potentially become part of the general treatment of psoriasis, especially in patients with obesity."

Patients with type 2 diabetes and obstructive sleep apnea who used continuous positive airway pressure (CPAP) saw improved glycemic control during the night.

More cases of blood cancers classified as non-Hodgkin's lymphoma, or NHL, seem to occur among people with diabetes than those without, researchers report.

Study urges supplementation of vitamin D to protect bones later in life for those children found to be deficient in vitamin D (75%).

Recent studies showing that gastric bypass surgery extends the lives of obese patients is forcing surgeons to make tough decisions about who should go under the knife and who shouldn't.